Enhanced Group is trading at $8.17, up 11.6%, as the company announced expanded peptide access; reports do not confirm the announcement is driving the move.
- On November 3, 2026, the company announced prescription-only access to six additional peptides through its Live Enhanced telehealth platform, with prescribing and oversight by licensed clinicians.
- Shares closed at $7.32 on November 2, after falling 22.38%; the live price context shows a rebound during the November 3 session.
- No trading-volume figure was available in the cited reports.